MHRP's HIV acute cohorts, RV217 and RV254, provide insight into crucial stages of early HIV infection. The acute, or first stage of HIV infection immediately follows exposure to the virus and... Read More
You are here
COL Kim Provides Commentary for Series, "30 years in 30 weeks"
MHRP's COL Jerome Kim provided an interesting commentary in a series by the Global HIV Vaccine Enterprise called "30 years in 30 weeks." COL Kim reflects on the RV144 trial and some of the challenges encountered on the road to success.